<--- Back to Details
First PageDocument Content
Biology / Encephalitis / Viruses / Japanese encephalitis / West Nile virus / La Crosse encephalitis / Viral encephalitis / Health / Microbiology
Date: 2012-08-25 01:27:29
Biology
Encephalitis
Viruses
Japanese encephalitis
West Nile virus
La Crosse encephalitis
Viral encephalitis
Health
Microbiology

Japanese Encephalitis Japanese encephalitis is a mosquito–borne viral disease that affects horses, donkeys, pigs and humans. Birds are reservoir hosts. Japanese encephalitis can be a very serious disease: although most

Add to Reading List

Source URL: www.qldhorsecouncil.com

Download Document from Source Website

File Size: 110,71 KB

Share Document on Facebook

Similar Documents

Soma markt wolkersdorf. Louis encephalitis principally affects wlkersdorf elderly, whereas Japanese encephalitis and eastern equine encephalitis have a wolkersdofr incidence, striking both soma markt wolkersdorf and elde

Soma markt wolkersdorf. Louis encephalitis principally affects wlkersdorf elderly, whereas Japanese encephalitis and eastern equine encephalitis have a wolkersdofr incidence, striking both soma markt wolkersdorf and elde

DocID: 1tcQH - View Document

JAPANESE ENCEPHALITIS Aetiology Epidemiology Diagnosis Prevention and Control References AETIOLOGY Classification of the causative agent Japanese encephalitis (JE) virus is a member of the family Flaviviridae, genus Flav

JAPANESE ENCEPHALITIS Aetiology Epidemiology Diagnosis Prevention and Control References AETIOLOGY Classification of the causative agent Japanese encephalitis (JE) virus is a member of the family Flaviviridae, genus Flav

DocID: 1slxi - View Document

Microsoft PowerPoint - W_Bossert_Molekulare Diagnostik 2013_WNV.ppt

Microsoft PowerPoint - W_Bossert_Molekulare Diagnostik 2013_WNV.ppt

DocID: 1r6Sk - View Document

FOR IMMEDIATE RELEASE Contact: Dr. Elliot Parks, HAWAII BIOTECH INITIATES PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE (HONOLULU, August 25, Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D.,

FOR IMMEDIATE RELEASE Contact: Dr. Elliot Parks, HAWAII BIOTECH INITIATES PHASE 1 CLINICAL TRIAL FOR DENGUE VACCINE (HONOLULU, August 25, Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D.,

DocID: 1qQgO - View Document

Microsoft Word - WEBSITE TBE GRANT RELEASE.doc

Microsoft Word - WEBSITE TBE GRANT RELEASE.doc

DocID: 1qLjw - View Document